2020 Highlights in Canadian Life Sciences IP and Regulatory Law | Smart & Biggar
1. COVID-19: CIPO, Federal Courts, Health Canada In response to the pandemic, we saw quick action and flexibility from: the Canadian Intellectual Property Office (CIPO) – deadlines from March 16 to August 28 were extended until August 31. On December 14, the Trademarks Office began accepting requests for expedited examination of trademark applications associated with medical goods or services related to COVID-19; the Federal Courts – Federal Court (FC) deadlines were suspended until June 29 or July 13, depending on the province, and a number of hearings and patent trials were conducted ...